Gopesh Tilvawala’s path to San Diego spans four countries and four continents. That journey led him to UC San Diego and the pursuit of a Ph.D. in mechanical and aerospace engineering with a focus on medical device technology. For the past four years, he’s been working to develop a first-of-its-kind catheter that can be remotely controlled to navigate the tiny arteries in the brain.
University of California San Diego School of Medicine researchers engineered sensors to detect and measure the metastatic potential of single cancer cells. Metastasis is attributed as the leading cause of death in people with cancer.
UC San Diego Medical Center in Hillcrest was named a Top Teaching Hospital by The Leapfrog Group. The award is widely acknowledged as one of the most competitive honors that a U.S. hospital can receive.
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.
The first in-depth look at the genome of a jellyfish reveals the origins of a successful survival strategy. Results indicate early jellyfish recycled existing genes to morph from polyp to medusa and suggest animals can radiate into new niches and forms fairly easily.
Following the FDA’s approval of chimeric antigen receptor (CAR) T-cell therapies for the treatment of certain types of non-Hodgkin lymphomas, UC San Diego Health was the first medical center in San Diego to be certified to offer this type of immunotherapy outside of a clinical trial.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
